nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—ABCB1—hematologic cancer	0.142	1	CbGaD
Astemizole—ABCB1—Lenalidomide—hematologic cancer	0.0249	0.0317	CbGbCtD
Astemizole—CYP3A7—Ifosfamide—hematologic cancer	0.024	0.0305	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.024	0.0305	CbGbCtD
Astemizole—CYP3A7—Imatinib—hematologic cancer	0.0229	0.0292	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0229	0.0292	CbGbCtD
Astemizole—CYP3A5—Daunorubicin—hematologic cancer	0.0225	0.0285	CbGbCtD
Astemizole—CYP2D6—Lomustine—hematologic cancer	0.0218	0.0278	CbGbCtD
Astemizole—CYP3A5—Thalidomide—hematologic cancer	0.0205	0.026	CbGbCtD
Astemizole—CYP3A5—Teniposide—hematologic cancer	0.0195	0.0248	CbGbCtD
Astemizole—CYP2D6—Idarubicin—hematologic cancer	0.0195	0.0247	CbGbCtD
Astemizole—CYP3A5—Ifosfamide—hematologic cancer	0.018	0.0229	CbGbCtD
Astemizole—CYP3A5—Imatinib—hematologic cancer	0.0172	0.0219	CbGbCtD
Astemizole—CYP2D6—Hydroxyurea—hematologic cancer	0.0165	0.021	CbGbCtD
Astemizole—CYP3A4—Bexarotene—hematologic cancer	0.0149	0.019	CbGbCtD
Astemizole—ABCB1—Daunorubicin—hematologic cancer	0.0146	0.0186	CbGbCtD
Astemizole—CYP2D6—Bortezomib—hematologic cancer	0.0144	0.0183	CbGbCtD
Astemizole—CYP3A7—Irinotecan—hematologic cancer	0.0143	0.0182	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0143	0.0182	CbGbCtD
Astemizole—ABCB1—Alitretinoin—hematologic cancer	0.0143	0.0182	CbGbCtD
Astemizole—CYP3A4—Busulfan—hematologic cancer	0.0139	0.0177	CbGbCtD
Astemizole—CYP3A4—Lomustine—hematologic cancer	0.0139	0.0177	CbGbCtD
Astemizole—CYP3A5—Dasatinib—hematologic cancer	0.0138	0.0176	CbGbCtD
Astemizole—CYP3A7—Vincristine—hematologic cancer	0.0125	0.0159	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0125	0.0159	CbGbCtD
Astemizole—CYP3A4—Thiotepa—hematologic cancer	0.0124	0.0157	CbGbCtD
Astemizole—ABCB1—Imatinib—hematologic cancer	0.0112	0.0142	CbGbCtD
Astemizole—CYP3A5—Irinotecan—hematologic cancer	0.0107	0.0137	CbGbCtD
Astemizole—CYP2D6—Imatinib—hematologic cancer	0.0105	0.0134	CbGbCtD
Astemizole—ABCB1—Nilotinib—hematologic cancer	0.0102	0.0129	CbGbCtD
Astemizole—ABCB1—Vinorelbine—hematologic cancer	0.0101	0.0128	CbGbCtD
Astemizole—CYP3A4—Methoxsalen—hematologic cancer	0.00962	0.0122	CbGbCtD
Astemizole—CYP2D6—Nilotinib—hematologic cancer	0.00959	0.0122	CbGbCtD
Astemizole—CYP2D6—Vinorelbine—hematologic cancer	0.00951	0.0121	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00943	0.012	CbGbCtD
Astemizole—CYP3A7—Dexamethasone—hematologic cancer	0.00943	0.012	CbGbCtD
Astemizole—CYP3A5—Vincristine—hematologic cancer	0.00939	0.0119	CbGbCtD
Astemizole—CYP3A4—Bortezomib—hematologic cancer	0.00915	0.0116	CbGbCtD
Astemizole—ABCB1—Dasatinib—hematologic cancer	0.00899	0.0114	CbGbCtD
Astemizole—ABCB1—Mitoxantrone—hematologic cancer	0.00888	0.0113	CbGbCtD
Astemizole—CYP3A4—Daunorubicin—hematologic cancer	0.00876	0.0111	CbGbCtD
Astemizole—CYP3A5—Etoposide—hematologic cancer	0.00861	0.0109	CbGbCtD
Astemizole—ABCB1—Betamethasone—hematologic cancer	0.00792	0.0101	CbGbCtD
Astemizole—ABCB1—Gemcitabine—hematologic cancer	0.00785	0.00997	CbGbCtD
Astemizole—ABCB1—Prednisolone—hematologic cancer	0.00781	0.00993	CbGbCtD
Astemizole—CYP3A4—Cytarabine—hematologic cancer	0.00772	0.00982	CbGbCtD
Astemizole—CYP3A4—Teniposide—hematologic cancer	0.00761	0.00967	CbGbCtD
Astemizole—ABCB1—Prednisone—hematologic cancer	0.00738	0.00938	CbGbCtD
Astemizole—CYP3A5—Dexamethasone—hematologic cancer	0.00708	0.00899	CbGbCtD
Astemizole—CYP3A4—Ifosfamide—hematologic cancer	0.00702	0.00893	CbGbCtD
Astemizole—ABCB1—Irinotecan—hematologic cancer	0.00699	0.00889	CbGbCtD
Astemizole—CYP3A4—Imatinib—hematologic cancer	0.00671	0.00853	CbGbCtD
Astemizole—CYP3A4—Ruxolitinib—hematologic cancer	0.00632	0.00803	CbGbCtD
Astemizole—ABCB1—Vinblastine—hematologic cancer	0.00622	0.0079	CbGbCtD
Astemizole—ABCB1—Vincristine—hematologic cancer	0.00611	0.00777	CbGbCtD
Astemizole—CYP3A4—Nilotinib—hematologic cancer	0.0061	0.00775	CbGbCtD
Astemizole—CYP3A4—Vinorelbine—hematologic cancer	0.00604	0.00768	CbGbCtD
Astemizole—CYP2D6—Vinblastine—hematologic cancer	0.00586	0.00745	CbGbCtD
Astemizole—ABCB1—Cisplatin—hematologic cancer	0.0057	0.00725	CbGbCtD
Astemizole—ABCB1—Etoposide—hematologic cancer	0.0056	0.00712	CbGbCtD
Astemizole—CYP3A4—Triamcinolone—hematologic cancer	0.00553	0.00703	CbGbCtD
Astemizole—CYP3A4—Dasatinib—hematologic cancer	0.00539	0.00685	CbGbCtD
Astemizole—CYP3A4—Mitoxantrone—hematologic cancer	0.00532	0.00676	CbGbCtD
Astemizole—CYP3A4—Betamethasone—hematologic cancer	0.00474	0.00603	CbGbCtD
Astemizole—CYP3A4—Prednisolone—hematologic cancer	0.00468	0.00595	CbGbCtD
Astemizole—ABCB1—Dexamethasone—hematologic cancer	0.0046	0.00585	CbGbCtD
Astemizole—CYP3A4—Prednisone—hematologic cancer	0.00442	0.00562	CbGbCtD
Astemizole—CYP2D6—Dexamethasone—hematologic cancer	0.00434	0.00552	CbGbCtD
Astemizole—CYP3A4—Irinotecan—hematologic cancer	0.00419	0.00533	CbGbCtD
Astemizole—ABCB1—Doxorubicin—hematologic cancer	0.00382	0.00486	CbGbCtD
Astemizole—CYP3A4—Vinblastine—hematologic cancer	0.00372	0.00474	CbGbCtD
Astemizole—ABCB1—Methotrexate—hematologic cancer	0.0037	0.0047	CbGbCtD
Astemizole—CYP3A4—Vincristine—hematologic cancer	0.00366	0.00466	CbGbCtD
Astemizole—CYP2D6—Doxorubicin—hematologic cancer	0.0036	0.00458	CbGbCtD
Astemizole—CYP3A4—Etoposide—hematologic cancer	0.00336	0.00427	CbGbCtD
Astemizole—CYP3A4—Dexamethasone—hematologic cancer	0.00276	0.00351	CbGbCtD
Astemizole—CYP3A4—Doxorubicin—hematologic cancer	0.00229	0.00291	CbGbCtD
Astemizole—CYP2D6—Metabolism—SPHK1—hematologic cancer	9.43e-06	0.000131	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	9.41e-06	0.000131	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SLC22A1—hematologic cancer	9.35e-06	0.00013	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CRABP1—hematologic cancer	9.35e-06	0.00013	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	9.27e-06	0.000129	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTM1—hematologic cancer	9.25e-06	0.000129	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NCOR1—hematologic cancer	9.25e-06	0.000129	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PARP1—hematologic cancer	9.16e-06	0.000128	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ALOX5—hematologic cancer	9.11e-06	0.000127	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.11e-06	0.000127	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—UGT1A1—hematologic cancer	9.06e-06	0.000126	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FBXW7—hematologic cancer	9.01e-06	0.000126	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTAP—hematologic cancer	8.94e-06	0.000125	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCR4—hematologic cancer	8.83e-06	0.000123	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HDAC2—hematologic cancer	8.83e-06	0.000123	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NUP98—hematologic cancer	8.82e-06	0.000123	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.81e-06	0.000123	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.81e-06	0.000123	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CD44—hematologic cancer	8.73e-06	0.000122	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NQO1—hematologic cancer	8.73e-06	0.000122	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CBL—hematologic cancer	8.61e-06	0.00012	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.58e-06	0.00012	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ADCY7—hematologic cancer	8.57e-06	0.000119	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NCOA3—hematologic cancer	8.57e-06	0.000119	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL3—hematologic cancer	8.52e-06	0.000119	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NUP214—hematologic cancer	8.5e-06	0.000119	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	8.42e-06	0.000117	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTPN1—hematologic cancer	8.37e-06	0.000117	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTR—hematologic cancer	8.33e-06	0.000116	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ABCG2—hematologic cancer	8.33e-06	0.000116	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NUP98—hematologic cancer	8.31e-06	0.000116	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	8.27e-06	0.000115	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYCS—hematologic cancer	8.26e-06	0.000115	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	8.24e-06	0.000115	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	8.21e-06	0.000114	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SYK—hematologic cancer	8.21e-06	0.000114	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	8.21e-06	0.000114	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MTHFR—hematologic cancer	8.18e-06	0.000114	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ENO2—hematologic cancer	8.17e-06	0.000114	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	8.15e-06	0.000114	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.07e-06	0.000112	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.07e-06	0.000112	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PIK3CA—hematologic cancer	8.05e-06	0.000112	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NUP214—hematologic cancer	8.01e-06	0.000112	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CREB1—hematologic cancer	8.01e-06	0.000112	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—FHL2—hematologic cancer	7.97e-06	0.000111	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTT1—hematologic cancer	7.93e-06	0.00011	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT1—hematologic cancer	7.92e-06	0.00011	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.85e-06	0.000109	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTR—hematologic cancer	7.85e-06	0.000109	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL2—hematologic cancer	7.84e-06	0.000109	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6R—hematologic cancer	7.81e-06	0.000109	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—AGRN—hematologic cancer	7.81e-06	0.000109	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SDC1—hematologic cancer	7.75e-06	0.000108	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ENO2—hematologic cancer	7.7e-06	0.000107	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	7.69e-06	0.000107	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.69e-06	0.000107	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	7.48e-06	0.000104	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.47e-06	0.000104	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	7.45e-06	0.000104	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.42e-06	0.000103	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GRB2—hematologic cancer	7.41e-06	0.000103	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HMMR—hematologic cancer	7.41e-06	0.000103	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—IDH2—hematologic cancer	7.41e-06	0.000103	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	7.4e-06	0.000103	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFA—hematologic cancer	7.39e-06	0.000103	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SDC1—hematologic cancer	7.3e-06	0.000102	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KITLG—hematologic cancer	7.29e-06	0.000102	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTP1—hematologic cancer	7.28e-06	0.000101	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT5A—hematologic cancer	7.12e-06	9.92e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	7.1e-06	9.9e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	7.06e-06	9.84e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	6.99e-06	9.74e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.96e-06	9.7e-05	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.95e-06	9.68e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ABCB1—hematologic cancer	6.89e-06	9.6e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CG—hematologic cancer	6.87e-06	9.58e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD86—hematologic cancer	6.83e-06	9.51e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—JAK2—hematologic cancer	6.79e-06	9.46e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CA9—hematologic cancer	6.77e-06	9.44e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ACP5—hematologic cancer	6.77e-06	9.44e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HES1—hematologic cancer	6.73e-06	9.38e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NCOR1—hematologic cancer	6.7e-06	9.33e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTM1—hematologic cancer	6.69e-06	9.32e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NCOR1—hematologic cancer	6.69e-06	9.32e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.69e-06	9.32e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CSF2—hematologic cancer	6.62e-06	9.23e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGF1—hematologic cancer	6.62e-06	9.23e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CD44—hematologic cancer	6.59e-06	9.18e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NQO1—hematologic cancer	6.59e-06	9.18e-05	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—AKT1—hematologic cancer	6.58e-06	9.17e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FOXO1—hematologic cancer	6.52e-06	9.09e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—IL2—hematologic cancer	6.52e-06	9.09e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	6.51e-06	9.08e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	6.45e-06	8.99e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	6.41e-06	8.93e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PRKCG—hematologic cancer	6.39e-06	8.9e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JAK1—hematologic cancer	6.39e-06	8.9e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CREBBP—hematologic cancer	6.37e-06	8.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—IDH1—hematologic cancer	6.37e-06	8.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.3e-06	8.78e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TXN—hematologic cancer	6.3e-06	8.78e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.3e-06	8.78e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYCS—hematologic cancer	6.23e-06	8.69e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NQO1—hematologic cancer	6.21e-06	8.65e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CD44—hematologic cancer	6.21e-06	8.65e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HSP90AA1—hematologic cancer	6.19e-06	8.63e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.16e-06	8.59e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CD—hematologic cancer	6.04e-06	8.42e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2RA—hematologic cancer	5.97e-06	8.32e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ALB—hematologic cancer	5.96e-06	8.31e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL2—hematologic cancer	5.92e-06	8.25e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.92e-06	8.25e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.91e-06	8.24e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TERT—hematologic cancer	5.9e-06	8.22e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYCS—hematologic cancer	5.87e-06	8.18e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.84e-06	8.13e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.76e-06	8.03e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.76e-06	8.03e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDGFB—hematologic cancer	5.76e-06	8.03e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3R1—hematologic cancer	5.7e-06	7.95e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TSC2—hematologic cancer	5.63e-06	7.84e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.61e-06	7.82e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTP1—hematologic cancer	5.49e-06	7.66e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NUP98—hematologic cancer	5.44e-06	7.58e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGFR3—hematologic cancer	5.41e-06	7.55e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAPK14—hematologic cancer	5.36e-06	7.47e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.28e-06	7.35e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.28e-06	7.35e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CB—hematologic cancer	5.27e-06	7.34e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ESR1—hematologic cancer	5.26e-06	7.33e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NUP214—hematologic cancer	5.24e-06	7.3e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FN1—hematologic cancer	5.19e-06	7.24e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.18e-06	7.21e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTR—hematologic cancer	5.13e-06	7.15e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.13e-06	7.15e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BAD—hematologic cancer	5.13e-06	7.15e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	5.13e-06	7.15e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	5.08e-06	7.08e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NCOR1—hematologic cancer	5.05e-06	7.03e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTM1—hematologic cancer	5.05e-06	7.03e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ENO2—hematologic cancer	5.03e-06	7.02e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD80—hematologic cancer	4.98e-06	6.94e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KIT—hematologic cancer	4.97e-06	6.93e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	4.97e-06	6.93e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—NRAS—hematologic cancer	4.97e-06	6.93e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.97e-06	6.92e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.9e-06	6.83e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTPN11—hematologic cancer	4.88e-06	6.81e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.88e-06	6.8e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SDC1—hematologic cancer	4.77e-06	6.65e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	4.76e-06	6.63e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.76e-06	6.63e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.76e-06	6.63e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CREB1—hematologic cancer	4.73e-06	6.59e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—BRAF—hematologic cancer	4.67e-06	6.51e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL2—hematologic cancer	4.63e-06	6.45e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6R—hematologic cancer	4.62e-06	6.43e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CREBBP—hematologic cancer	4.61e-06	6.42e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.61e-06	6.42e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PTEN—hematologic cancer	4.55e-06	6.34e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTHFR—hematologic cancer	4.46e-06	6.22e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	4.4e-06	6.13e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	4.37e-06	6.09e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CD—hematologic cancer	4.37e-06	6.09e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—EP300—hematologic cancer	4.34e-06	6.05e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.33e-06	6.03e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ALB—hematologic cancer	4.31e-06	6.01e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—KRAS—hematologic cancer	4.28e-06	5.96e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.2e-06	5.86e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGF2—hematologic cancer	4.18e-06	5.83e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	4.13e-06	5.75e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.12e-06	5.75e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NQO1—hematologic cancer	4.06e-06	5.65e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CD44—hematologic cancer	4.06e-06	5.65e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JAK2—hematologic cancer	4.01e-06	5.59e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	3.93e-06	5.48e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MDM2—hematologic cancer	3.92e-06	5.46e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYCS—hematologic cancer	3.84e-06	5.35e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.82e-06	5.32e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.81e-06	5.31e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.81e-06	5.31e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.81e-06	5.3e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.75e-06	5.22e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HRAS—hematologic cancer	3.64e-06	5.07e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	3.57e-06	4.98e-05	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	3.54e-06	4.93e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.53e-06	4.92e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CASP3—hematologic cancer	3.5e-06	4.88e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2—hematologic cancer	3.5e-06	4.88e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—hematologic cancer	3.48e-06	4.85e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CREBBP—hematologic cancer	3.48e-06	4.84e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCND1—hematologic cancer	3.41e-06	4.75e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JUN—hematologic cancer	3.4e-06	4.74e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.38e-06	4.72e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	3.3e-06	4.6e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.3e-06	4.59e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTEN—hematologic cancer	3.29e-06	4.59e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PTEN—hematologic cancer	3.29e-06	4.58e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.27e-06	4.56e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ALB—hematologic cancer	3.25e-06	4.53e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAPK8—hematologic cancer	3.22e-06	4.49e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—AKT1—hematologic cancer	3.21e-06	4.48e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PIK3CA—hematologic cancer	3.21e-06	4.47e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.2e-06	4.46e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EP300—hematologic cancer	3.14e-06	4.37e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—EP300—hematologic cancer	3.14e-06	4.37e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.11e-06	4.34e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.11e-06	4.33e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.11e-06	4.33e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.11e-06	4.33e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ALB—hematologic cancer	3.07e-06	4.27e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SRC—hematologic cancer	3.05e-06	4.25e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.97e-06	4.14e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.94e-06	4.1e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.94e-06	4.09e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.93e-06	4.09e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.87e-06	4e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.81e-06	3.92e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.75e-06	3.83e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MYC—hematologic cancer	2.74e-06	3.81e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.73e-06	3.8e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.71e-06	3.77e-05	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—AKT1—hematologic cancer	2.62e-06	3.65e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.53e-06	3.52e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PTEN—hematologic cancer	2.48e-06	3.46e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—EP300—hematologic cancer	2.37e-06	3.3e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PTEN—hematologic cancer	2.34e-06	3.26e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.32e-06	3.24e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.32e-06	3.23e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.31e-06	3.22e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TP53—hematologic cancer	2.25e-06	3.13e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—EP300—hematologic cancer	2.23e-06	3.11e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HRAS—hematologic cancer	2.15e-06	2.99e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.14e-06	2.98e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—hematologic cancer	2.06e-06	2.87e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.03e-06	2.83e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ALB—hematologic cancer	2e-06	2.79e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.92e-06	2.67e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.9e-06	2.64e-05	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—AKT1—hematologic cancer	1.9e-06	2.64e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.77e-06	2.47e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.65e-06	2.3e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PTEN—hematologic cancer	1.53e-06	2.13e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—EP300—hematologic cancer	1.46e-06	2.03e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—AKT1—hematologic cancer	1.43e-06	1.99e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—AKT1—hematologic cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.5e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—AKT1—hematologic cancer	8.81e-07	1.23e-05	CbGpPWpGaD
